谷歌浏览器插件
订阅小程序
在清言上使用

P-63 Efficacy, Safety and Prognostic Subgroups for Outcome with Regorafenib in Patients with Refractory Metastatic Colorectal Cancer in the Real-World Setting: the CORE Study

Annals of oncology(2022)

引用 0|浏览31
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要